as on October 16, 2025 at 1:29 am IST
Day's Low
Day's High
6.60%
Downside
-0.06%
Upside
52 Week's Low
52 Week's High
75.06%
Downside
-6.89%
Upside
Check Adaptive Biotechnologies Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.4B
EPS (TTM)
-0.6957
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.23
Industry PE ratio
-0.32286624203821657
PEG Ratio
0EBITDA
-102.8M
Revenue (TTM)
205.2M
Profit Margin
-59.07%
Return On Equity TTM
0.00%
Track how Adaptive Biotechnologies Corp P/E has moved over time to understand its valuation trends.
Adaptive Biotechnologies Corp in the last 5 years
Lowest (-47.07x)
March 31, 2021
Today (-3.23x)
October 15, 2025
Industry (-0.32x)
October 15, 2025
Highest (-2.46x)
June 30, 2024
Today’s Price to Earnings Ratio: -3.23x
Compare market cap, revenue, PE, and other key metrics of Adaptive Biotechnologies Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.4B | -69.71% | -3.23 | -59.07% | |
BUY | $60.9B | 226.08% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $104.4B | 91.48% | 28.99 | 31.86% | |
BUY | $59.1B | -2.15% | 14.07 | 31.37% |
The Adaptive Biotechnologies Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Adaptive Biotechnologies Corp investment value today
Current value as on today
₹3,49,298
Returns
₹2,49,298
(+249.3%)
Returns from Adaptive Biotechnologies Corp Stock
₹2,44,467 (+244.47%)
Dollar Returns*
₹4,831 (+4.83%)
Based on 14 analysts
78.57%
Buy
21.43%
Hold
0.00%
Sell
Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Adaptive Biotechnologies Corp. Average target price of $15.29
Get share price movements and forecasts by analysts on Adaptive Biotechnologies Corp.
What analysts predicted
-11.97%DOWNSIDE
Target Price
$15.29
Current Price
$17.12
Analyzed by
14 Analysts
Target
$15.29
Adaptive Biotechnologies Corp target price $15.29, a slight downside of -11.97% compared to current price of $17.12. According to 14 analysts rating.
Search interest for Adaptive Biotechnologies Corp Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:100% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, -33.69M → -25.61M (in $), with an average increase of 14.7% per quarter
Revenue Rich
Revenue is up for the last 6 quarters, 41.87M → 58.87M (in $), with an average increase of 6.5% per quarter
Best in 1 Year
In the last 1 year, ADPT has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 1 year, ADPT stock has moved up by 213.5%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.0% return, outperforming this stock by 4.1%
Organisation | Adaptive Biotechnologies Corp |
Headquarters | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Industry | Commercial Services |
CEO | Mr. Chad M. Robins M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Julie Rubinstein | President & COO |
Dr. Harlan S. Robins Ph.D. | Co-Founder & Chief Scientific Officer |
Dr. Sharon Benzeno Ph.D. | Chief Commercial Officer of Immune Medicine |
Ms. Karina Calzadilla | Vice President of Investor Relations |
Ms. Clarice McCauley | Interim General Counsel, Corporate Secretary, VP & Chief Compliance Officer |
Mr. Francis T. Lo | Chief People Officer |
Ms. Susan Bobulsky | Chief Commercial Officer of MRD |
Mr. Chad M. Robins M.B.A. | Co-Founder, CEO & Chairman |
Mr. Christopher Carlson Ph.D. | Founder |
Mr. Kyle Piskel | VP, CFO & Principal Accounting Officer |
Adaptive Biotechnologies Corp share price today is $17.12 as on at the close of the market. Adaptive Biotechnologies Corp share today touched a day high of $17.11 and a low of $15.99.
Adaptive Biotechnologies Corp share touched a 52 week high of $15.94 on and a 52 week low of $4.27 on . Adaptive Biotechnologies Corp stock price today i.e. is closed at $17.12,which is -7.40% down from its 52 week high and 300.94% up from its 52 week low.
Adaptive Biotechnologies Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Adaptive Biotechnologies Corp (ADPT) shares with as little as ₹87.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Adaptive Biotechnologies Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Adaptive Biotechnologies Corp share’s latest price of $17.12 as on October 16, 2025 at 1:29 am IST, you will get 0.5841 shares of Adaptive Biotechnologies Corp. Learn more about
fractional shares .
Adaptive Biotechnologies Corp stock has given -69.71% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?